Maravai LifeSciences Holdings バランスシートの健全性
財務の健全性 基準チェック /46
Maravai LifeSciences Holdingsの総株主資本は$776.4M 、総負債は$522.5Mで、負債比率は67.3%となります。総資産と総負債はそれぞれ$1.4Bと$671.2Mです。
主要情報
67.3%
負債資本比率
US$522.52m
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | US$579.75m |
| エクイティ | US$776.41m |
| 負債合計 | US$671.19m |
| 総資産 | US$1.45b |
財務の健全性に関する最新情報
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Oct 15
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Jul 15Recent updates
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Oct 15Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors
Jul 18Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Jul 15Maravai: Embedded Expectations Remain Too High Considering Economic Calculus
Jul 12RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One
Jun 12Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%
May 14An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29Maravai Faces Skeptical Investors As Pandemic Enters New Period
Jan 27財務状況分析
短期負債: MRVIの 短期資産 ( $685.4M ) が 短期負債 ( $68.6M ) を超えています。
長期負債: MRVIの短期資産 ( $685.4M ) が 長期負債 ( $602.6M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: MRVI総負債よりも多くの現金を保有しています。
負債の削減: MRVIの負債対資本比率は、過去 5 年間で230.8%から67.3%に減少しました。
債務返済能力: MRVIの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 5.9% )。
インタレストカバレッジ: MRVIの負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。